Human monoclonal antibodies specific for capsular polysaccharides of Klebsiella recognize clusters of multiple serotypes
- PMID: 2016541
Human monoclonal antibodies specific for capsular polysaccharides of Klebsiella recognize clusters of multiple serotypes
Abstract
We report the generation and the characterization of a set of human monoclonal antibodies (HmAb) specific for Gram-negative bacteria of Klebsiella pneumoniae. The eight human hybridomas secrete either IgM kappa, IgA1 kappa, or IgA2 kappa antibodies. One HmAb binds bacteria of only one serotype. Five HmAb recognize non-overlapping clusters of 2, 3, or 10 different serotypes. The remaining two HmAb both recognize three serotypes. Two serotypes are recognized by both HmAb, and in addition both HmAb bind one more nonidentical serotype. These results suggest that in man, epitopes are immunodominant, different from serotype-specific determinants detected by conventional rabbit antisera. Screening of clinical isolates revealed that the HmAb recognize not only representative typing strains but also most isolates of the corresponding serotype. In addition, most of the isolates that were non-typable by polyclonal antisera were recognized by one of the HmAb. Fine specificity analyses revealed that all HmAb are highly specific for the isolated capsular polysaccharides (CPS) of bacteria within the corresponding cluster of serotypes. However, the avidity of a HmAb for the different CPS can differ significantly. Taken together, our results suggest that the unequivocal interactions between HmAb and CPS offer the basis for an alternative, better defined classification system, and that passive immunization with a limited number of HmAb may provide a feasible strategy for the protection against the majority of fatal, nosocomial infections with multidrug-resistant strains of K. pneumoniae.
Similar articles
-
Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides.Dev Biol Stand. 1990;71:121-6. Dev Biol Stand. 1990. PMID: 1698165
-
Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.Hum Antibodies Hybridomas. 1990;1(2):96-103. Hum Antibodies Hybridomas. 1990. PMID: 2129420
-
Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.Vaccine. 2008 Oct 16;26(44):5649-53. doi: 10.1016/j.vaccine.2008.07.100. Epub 2008 Aug 24. Vaccine. 2008. PMID: 18725260
-
Serogroup and serotype classification of bacterial pathogens.Methods Enzymol. 1994;235:159-74. doi: 10.1016/0076-6879(94)35138-4. Methods Enzymol. 1994. PMID: 8057893 Review. No abstract available.
-
Progress in immunization against Klebsiella infections.Eur J Clin Microbiol. 1983 Dec;2(6):523-8. doi: 10.1007/BF02016559. Eur J Clin Microbiol. 1983. PMID: 6365535 Review.
Cited by
-
The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections.Front Microbiol. 2022 Mar 7;13:835677. doi: 10.3389/fmicb.2022.835677. eCollection 2022. Front Microbiol. 2022. PMID: 35330773 Free PMC article. Review.
-
Patient-Derived Antibody Data Yields Development of Broadly Cross-Protective Monoclonal Antibody against ST258 Carbapenem-Resistant Klebsiella pneumoniae.Microbiol Spectr. 2022 Aug 31;10(4):e0176022. doi: 10.1128/spectrum.01760-22. Epub 2022 Jul 11. Microbiol Spectr. 2022. PMID: 35862974 Free PMC article.
-
A New Take on an Old Remedy: Generating Antibodies against Multidrug-Resistant Gram-Negative Bacteria in a Postantibiotic World.mSphere. 2017 Oct 4;2(5):e00397-17. doi: 10.1128/mSphere.00397-17. eCollection 2017 Sep-Oct. mSphere. 2017. PMID: 28989972 Free PMC article.
-
Carbapenem-resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traits.J Infect Dis. 2014 Sep 1;210(5):803-13. doi: 10.1093/infdis/jiu157. Epub 2014 Mar 14. J Infect Dis. 2014. PMID: 24634498 Free PMC article.
-
Protective effect of antilipopolysaccharide monoclonal antibody in experimental Klebsiella infection.Infect Immun. 1997 May;65(5):1754-60. doi: 10.1128/iai.65.5.1754-1760.1997. Infect Immun. 1997. PMID: 9125558 Free PMC article.